Document is current

Any future updates will be listed below

Design and biological evaluation of mesalamine–NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy

Crossref DOI link: https://doi.org/10.1038/s41598-025-31910-5

Published Online: 2025-12-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark